Carissa A Low1, Annette L Stanton2. 1. Biobehavioral Medicine in Oncology Program, University of Pittsburgh Cancer Institute, University of Pittsburgh. 2. Department of Psychology, University of California, Los Angeles.
Abstract
OBJECTIVE: Women with breast cancer are at increased risk of depression, and the extent to which valued activities are disrupted by one's illness has been correlated with depressive symptoms in women with early stage breast cancer. This association has not been examined in women with Stage IV (metastatic) cancer, and the temporal directionality of this relationship remains unclear. The goal of the current study was to examine longitudinal, reciprocal relationships between illness-related disruption of social and recreational activities and self-reported symptoms of depression in a sample of women living with Stage IV breast cancer. METHOD: Participants were 103 women diagnosed with metastatic breast cancer. Women completed measures of depressive symptoms and activity disruption at study entry (T1) and at 3-month follow-up (T2). RESULTS: Activity disruption at study entry did not significantly predict changes in total depressive symptoms or in negative affective or somatic symptoms but did predict reductions in positive affect. Total depressive symptoms at study entry predicted increases in activity disruption, as did negative affective symptoms. CONCLUSIONS: Depressive symptoms, specifically negative affective symptoms such as sadness, may exacerbate social and recreational activity disruption in women with metastatic breast cancer. Cancer-related activity disruption may, in turn, result in reductions in positive affect. These results highlight the importance of examining specific constellations of depressive symptoms and suggest that maintaining valued activities may help to preserve enjoyment of life for patients with Stage IV cancer.
OBJECTIVE:Women with breast cancer are at increased risk of depression, and the extent to which valued activities are disrupted by one's illness has been correlated with depressive symptoms in women with early stage breast cancer. This association has not been examined in women with Stage IV (metastatic) cancer, and the temporal directionality of this relationship remains unclear. The goal of the current study was to examine longitudinal, reciprocal relationships between illness-related disruption of social and recreational activities and self-reported symptoms of depression in a sample of women living with Stage IV breast cancer. METHOD:Participants were 103 women diagnosed with metastatic breast cancer. Women completed measures of depressive symptoms and activity disruption at study entry (T1) and at 3-month follow-up (T2). RESULTS: Activity disruption at study entry did not significantly predict changes in total depressive symptoms or in negative affective or somatic symptoms but did predict reductions in positive affect. Total depressive symptoms at study entry predicted increases in activity disruption, as did negative affective symptoms. CONCLUSIONS:Depressive symptoms, specifically negative affective symptoms such as sadness, may exacerbate social and recreational activity disruption in women with metastatic breast cancer. Cancer-related activity disruption may, in turn, result in reductions in positive affect. These results highlight the importance of examining specific constellations of depressive symptoms and suggest that maintaining valued activities may help to preserve enjoyment of life for patients with Stage IV cancer.
Authors: Jennifer Duke; Howard Leventhal; Susan Brownlee; Elaine A Leventhal Journal: J Gerontol B Psychol Sci Soc Sci Date: 2002-07 Impact factor: 4.077
Authors: Brent T Mausbach; Elizabeth A Chattillion; Raeanne C Moore; Susan K Roepke; Colin A Depp; Scott Roesch Journal: Clin Psychol Rev Date: 2011-04-28
Authors: Derek R Hopko; Maria E A Armento; Sarah M C Robertson; Marlena M Ryba; John P Carvalho; Lindsey K Colman; Christen Mullane; Michael Gawrysiak; John L Bell; James K McNulty; Carl W Lejuez Journal: J Consult Clin Psychol Date: 2011-10-10
Authors: Catherine E Mosher; Ellen Krueger; Adam T Hirsh; Kathy D Miller; Tarah J Ballinger; Anna Maria Storniolo; Bryan P Schneider; Erin V Newton; Victoria L Champion; Shelley A Johns Journal: Contemp Clin Trials Date: 2020-10-07 Impact factor: 2.226
Authors: Catherine E Mosher; Danielle B Tometich; Adam Hirsh; Kevin L Rand; Shelley A Johns; Marianne S Matthias; Samantha D Outcalt; Jonathan Bricker; Bryan Schneider; Lida Mina; Anna Maria Storniolo; Erin Newton; Kathy Miller Journal: Psychooncology Date: 2016-10-11 Impact factor: 3.894
Authors: Catherine E Mosher; Ekin Secinti; Ruohong Li; Adam T Hirsh; Jonathan Bricker; Kathy D Miller; Bryan Schneider; Anna Maria Storniolo; Lida Mina; Erin V Newton; Victoria L Champion; Shelley A Johns Journal: Support Care Cancer Date: 2018-01-12 Impact factor: 3.603
Authors: Heather S L Jim; Aasha I Hoogland; Naomi C Brownstein; Anna Barata; Adam P Dicker; Hans Knoop; Brian D Gonzalez; Randa Perkins; Dana Rollison; Scott M Gilbert; Ronica Nanda; Anders Berglund; Ross Mitchell; Peter A S Johnstone Journal: CA Cancer J Clin Date: 2020-04-20 Impact factor: 508.702
Authors: C E Mosher; S Daily; D Tometich; M S Matthias; S D Outcalt; A Hirsh; S A Johns; K Rand; B Schneider; L Mina; A M Storniolo; E Newton; K Miller Journal: Eur J Cancer Care (Engl) Date: 2016-07-27 Impact factor: 2.520
Authors: Timothy J Williamson; Susan M Love; Jessica N Clague DeHart; Alexandra Jorge-Miller; Leah Eshraghi; Heather Cooper Ortner; Annette L Stanton Journal: Breast Cancer Res Treat Date: 2018-05-16 Impact factor: 4.872
Authors: Mireia Margelí Vila; Sonia Del Barco Berron; Miguel Gil-Gil; Cristian Ochoa-Arnedo; Rafael Villanueva Vázquez Journal: Breast Date: 2020-06-26 Impact factor: 4.380
Authors: Danielle B Tometich; Kelly A Hyland; Hatem Soliman; Heather S L Jim; Laura Oswald Journal: Cancers (Basel) Date: 2020-12-08 Impact factor: 6.639